TLTFF (Theralase Technologies) Pretax Margin % : -223.61% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Theralase Technologies's Pre-Tax Income for the three months ended in Dec. 2024 was $-0.64 Mil. Theralase Technologies's Revenue for the three months ended in Dec. 2024 was $0.29 Mil. Therefore, Theralase Technologies's pretax margin for the quarter that ended in Dec. 2024 was -223.61%.

The historical rank and industry rank for Theralase Technologies's Pretax Margin % or its related term are showing as below:

TLTFF' s Pretax Margin % Range Over the Past 10 Years
Min: -769.09 Med: -419.6 Max: -193.6
Current: -411.7

TLTFF's Pretax Margin % is ranked worse than
88.41% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: 0.495 vs TLTFF: -411.70

Theralase Technologies Pretax Margin % Historical Data

The historical data trend for Theralase Technologies's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Pretax Margin % Chart

Theralase Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Pretax Margin %

Get a 7-Day Free Trial

-602.90

-564.92

-459.90

-426.94

-412.00

Theralase Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Pretax Margin %	Get a 7-Day Free Trial															-272.69	-720.00	-1,117.57	-270.31	-223.61

Competitive Comparison of Theralase Technologies's Pretax Margin %

For the Medical Devices subindustry, Theralase Technologies's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theralase Technologies's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Theralase Technologies's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Theralase Technologies's Pretax Margin % falls into.

Save Embed

;

Save Embed

;

Theralase Technologies Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Theralase Technologies's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-2.987	/	0.725
	=	-412.00 %

Theralase Technologies's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-0.644	/	0.288
	=	-223.61 %

Theralase Technologies (OTCPK:TLTFF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Theralase Technologies Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

TTX:Germany TTX:Germany TLT:Canada

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.